Herbalife Ltd. issued a scathing statement on hedge fund manager and shareholder activist Bill Ackman Friday. Ackman, who has amassed a large short position in Herbalife and repeatedly charged it with being a Ponzi scheme, is hosting an investor call to discuss his stake in troubled drug maker Valeant Pharmaceuticals International Inc. . "I hope Bill Ackman has done more research on Valeant than he did on Herbalife, Target, Borders and JC Penney," said Alan Hoffman, executive vice president, global corporate affairs, at Herbalife.
Copyright © 2015 MarketWatch, Inc.
Continue Reading Below